{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:F4JCU0",
      "entity_text" : "SUA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0079" ]
    }
  },
  "verbose_text" : "Eligible subjects were men or women aged between 18 and 85 years, with SUA levels of> 7.0 mg/dl with a history of gout, SUA levels of> = 8.0 mg/dl with complications (defined as a need for pharmacologic or other treatment for lithangiuria, hypertension, hyperlipidemia, or abnormal glucose tolerance) or SUA levels of> = 9.0 mg/dl without complications.",
  "reading_complete" : "2020-07-28T17:22:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:15:21Z",
  "trigger" : "levels",
  "evidence" : [ "SUA levels" ],
  "pmc_id" : "6858416",
  "score" : 0
}